BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2401 related articles for article (PubMed ID: 31530274)

  • 21. Staged revascularization vs. culprit-only percutaneous coronary intervention for multivessel disease in elderly patients with ST-segment elevation myocardial infarction.
    Lang J; Wang C; Wang L; Zhang J; Hu Y; Sun H; Cong H; Liu Y
    Front Cardiovasc Med; 2022; 9():943323. PubMed ID: 36158792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multivessel disease in patients over 75years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI+75 nation-wide registry.
    de La Torre Hernandez JM; Gomez Hospital JA; Baz JA; Brugaletta S; Perez de Prado A; Linares JA; Lopez Palop R; Cid B; Garcia Camarero T; Diego A; Gutierrez H; Fernandez Diaz JA; Sanchis J; Alfonso F; Blanco R; Botas J; Navarro Cuartero J; Moreu J; Bosa F; Vegas JM; Elizaga J; Arrebola AL; Hernandez F; Salvatella N; Monteagudo M; Gomez Jaume A; Carrillo X; Martin Reyes R; Lozano F; Rumoroso JR; Andraka L; Dominguez AJ
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):580-588. PubMed ID: 29306670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes of staged recanalization for concurrent chronic total occlusion in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Cui KY; Yuan F; Liu H; Xu F; Zhang M; Wang W; Zhang MD; Wang YL; Zhang DF; Zhang X; Tian JF; Lyu SZ
    J Geriatr Cardiol; 2020 Jan; 17(1):16-25. PubMed ID: 32133033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.
    Kolte D; Sardar P; Khera S; Zeymer U; Thiele H; Hochadel M; Radovanovic D; Erne P; Hambraeus K; James S; Claessen BE; Henriques JPS; Mylotte D; Garot P; Aronow WS; Owan T; Jain D; Panza JA; Frishman WH; Fonarow GC; Bhatt DL; Aronow HD; Abbott JD
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Culprit Vessel-Only vs. Staged Multivessel Percutaneous Coronary Intervention Strategies in Patients With Multivessel Coronary Artery Disease Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Toyota T; Shiomi H; Taniguchi T; Morimoto T; Furukawa Y; Nakagawa Y; Horie M; Kimura T;
    Circ J; 2016; 80(2):371-8. PubMed ID: 26597353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial culprit-only versus initial multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: results from the Ibaraki Cardiovascular Assessment Study registry.
    Abe D; Sato A; Hoshi T; Takeyasu N; Misaki M; Hayashi M; Aonuma K
    Heart Vessels; 2014 Mar; 29(2):171-7. PubMed ID: 23529625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
    Böhm F; Mogensen B; Engstrøm T; Stankovic G; Srdanovic I; Lønborg J; Zwackman S; Hamid M; Kellerth T; Lauermann J; Kajander OA; Andersson J; Linder R; Angerås O; Renlund H; Ērglis A; Menon M; Schultz C; Laine M; Held C; Rück A; Östlund O; James S;
    N Engl J Med; 2024 Apr; 390(16):1481-1492. PubMed ID: 38587995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes after culprit-only percutaneous coronary intervention for multivessel disease during ST-segment elevation myocardial infarction: a comparison of registry and clinical trial outcomes.
    Jackson MWP; Austin D; Swanson N; Williams PD; Muir DF; Hall JA; Wright RA; Sutton AGC; Carter J; de Belder MA
    Coron Artery Dis; 2018 Nov; 29(7):564-572. PubMed ID: 29944476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial.
    Denormandie P; Simon T; Cayla G; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; le Breton H; Valy Y; Schiele F; Cuisset T; Vanzetto G; Levesque S; Goube P; Nallet O; Angoulvant D; Roubille F; Charles Nelson A; Chatellier G; Danchin N; Puymirat E
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e011314. PubMed ID: 34420366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implication of QFR in patients with ST-segment elevation myocardial infarction after drug-eluting stent implantation.
    Tang J; Chu J; Hou H; Lai Y; Tu S; Chen F; Yao Y; Ye Z; Gao Y; Mao Y; Zhuang S; Liu X
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):755-766. PubMed ID: 33044717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
    Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA;
    Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
    Bainey KR; Mehta SR; Lai T; Welsh RC
    Am Heart J; 2014 Jan; 167(1):1-14.e2. PubMed ID: 24332136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2019 May; 284():102-109. PubMed ID: 30877937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials.
    Elgendy IY; Wen X; Mahmoud A; Bavry AA
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):501-505. PubMed ID: 26524970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of fractional flow reserve guided complete revascularization versus infarct related artery only revascularization in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.
    Neupane S; Singh H; Edla S; Altujjar M; Yamsaki H; Lalonde T; Rosman HS; Eggebrecht H; Mehta RH
    Coron Artery Dis; 2019 Sep; 30(6):393-397. PubMed ID: 31094897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes in myocardial infarction and multivessel disease after a cardiac rehabilitation programme: Partial versus complete revascularization.
    Mori Junco R; Dalmau Gonzalez-Gallarza R; Castro Conde A; González Fernandez O; Álvarez Ortega C; Blázquez Bermejo Z; Furuya-Kanamori L; Moreno Gomez R; López de Sa Arreses E
    Arch Cardiovasc Dis; 2017 Apr; 110(4):234-241. PubMed ID: 28082243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    Mehta SR; Wood DA; Storey RF; Mehran R; Bainey KR; Nguyen H; Meeks B; Di Pasquale G; López-Sendón J; Faxon DP; Mauri L; Rao SV; Feldman L; Steg PG; Avezum Á; Sheth T; Pinilla-Echeverri N; Moreno R; Campo G; Wrigley B; Kedev S; Sutton A; Oliver R; Rodés-Cabau J; Stanković G; Welsh R; Lavi S; Cantor WJ; Wang J; Nakamya J; Bangdiwala SI; Cairns JA;
    N Engl J Med; 2019 Oct; 381(15):1411-1421. PubMed ID: 31475795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 121.